Literature DB >> 91783

Non-surgical treatment of biliary obstruction.

J S Dooley, R Dick, J Olney, S Sherlock.   

Abstract

Bileduct catheterisation percutaneously through the liver can be used in patients with obstructive jaundice as an adjunct or as an alternative to surgery. Preoperative drainage allows adequate treatment of severe cholangitis and reduces jaundice. Palliative drainage, whether internal or external, can be used instead of surgery. Drainage through the liver succeeded in 40 of 41 patients. Two complications followed the procedure and were treated conservatively. Bile drainage was established through an endoprosthesis into the duodenum in 7 patients and externally through a catheter in the remaining 33. The technique is described, and its use in patients with suppurative cholangitis and benign and malignant biliary strictures is illustrated.

Entities:  

Mesh:

Year:  1979        PMID: 91783     DOI: 10.1016/s0140-6736(79)92442-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  Preoperative transhepatic biliary decompression in pancreatic and periampullary cancer.

Authors:  E C Ellison; M E Van Aman; L C Carey
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

2.  Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost?

Authors:  H A Pitt; A S Gomes; J F Lois; L L Mann; L S Deutsch; W P Longmire
Journal:  Ann Surg       Date:  1985-05       Impact factor: 12.969

3.  Effective palliation of malignant biliary duct obstruction.

Authors:  M A Malangoni; D M McCoy; J D Richardson; L M Flint
Journal:  Ann Surg       Date:  1985-05       Impact factor: 12.969

4.  Computer-aided selection of diagnostic tests in jaundiced patients.

Authors:  M F Saint-Marc Girardin; M Le Minor; A Alperovitch; F Roudot-Thoraval; J M Metreau; D Dhumeaux
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

5.  Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results.

Authors:  K E Bakkevold; B Kambestad
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

6.  Biliary excretion of rufloxacin in humans.

Authors:  G Privitera; G Nicastro; B P Imbimbo; M Cesana; M Visconti; F Lombardi; G Tagliabue; E Faleschini; F Colturani; P Franzini
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

7.  Granular cell myoblastoma of the common bile duct treated by biliary drainage and surgery.

Authors:  J Dewar; J S Dooley; I Lindsay; P George; S Sherlock
Journal:  Gut       Date:  1981-01       Impact factor: 23.059

8.  Percutaneous transhepatic management of complex biliary problems.

Authors:  G D Zuidema; J L Cameron; J V Sitzmann; S Kadir; G W Smith; S L Kaufman; R I White
Journal:  Ann Surg       Date:  1983-05       Impact factor: 12.969

9.  Cholangiocarcinoma. Role of percutaneous transhepatic cholangiography in determination of resectability.

Authors:  R B Lynn; J A Wilson; K J Cho
Journal:  Dig Dis Sci       Date:  1988-05       Impact factor: 3.199

10.  Biliary elimination of cyclophosphamide in man.

Authors:  J S Dooley; C A James; H J Rogers; R Stuart-Harris
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.